Get started
AIM ImmunoTech Inc.AIM ImmunoTech Inc.AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

No trades
See on Supercharts
Overview
Ideas Discussions Technicals Seasonals

AIM chart


Full chart

Employees


Employees (FY)
—
Revenue / Employee (1Y)
‪7.39 K‬
Net income / Employee (1Y)
‪−753.04 K‬

About AIM ImmunoTech Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Kenwood Equels
Website
aimimmuno.com
Headquarters
Ocala
Founded
1966
FIGI
BBG000JL6Z80
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as AIM.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange AIM ImmunoTech Inc. stocks are traded under the ticker AIM.
Today AIM ImmunoTech Inc. has the market capitalization of ‪7.26 M‬, it has increased by 30.99% over the last week.
AIM ImmunoTech Inc. is going to release the next earnings report on Aug 19, 2025. Keep track of upcoming events with our Earnings Calendar.
No, AIM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AIM ImmunoTech Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AIM ImmunoTech Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AIM ImmunoTech Inc. stock shows the buy signal. See more of AIM ImmunoTech Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.